Swayam Prakash Srivastava

9PUBLICATIONS
14CO-AUTHORS
Cell development, proliferation and deathMolecular targetsPharmacogenomicsEpigenetics (incl. genome methylation and epigenomics)Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 28, 2026
AMPK is dispensable for physiological podocyte and glomerular functions but prevents glomerular fibrosis in experimental diabetes.

Swayam Prakash Srivastava, Olivia Kopasz-Gemmen, Abhiram Kunamneni

|Apr 28, 2025
AMPK is dispensable for physiological podocyte and glomerular functions but prevents glomerular fibrosis in experimental diabetes.

Swayam Prakash Srivastava, Olivia Kopasz-Gemmen, Abhiram Kunamneni

|Dec 04, 2024
Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease.

Swayam Prakash Srivastava, Han Zhou, Rachel Shenoi

|Oct 28, 2023
Drugs for Diabetes: From Pharmacology to Clinical Application.

Swayam Prakash Srivastava

|Aug 17, 2023
Loss of endothelial glucocorticoid receptor accelerates organ fibrosis in db/db mice.

Swayam Prakash Srivastava, Julie E Goodwin

Pageof 2